Related Experiment Video
Updated: Apr 28, 2026
05:51
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
3.6K
Olanzapine-induced restless legs syndrome
Mangsuo Zhao1, Tongchao Geng1, Liyan Qiao1
1Department of Neurology, Yuquan Hospital, Medical Center, Tsinghua University, Beijing, PR China.
Summary
Olanzapine can cause restless legs syndrome (RLS), particularly in those with a family history. Discontinuing olanzapine is the most effective treatment for this drug-induced condition.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Restless Legs Syndrome (RLS) is a neurological disorder.
- Olanzapine is an atypical antipsychotic medication.
- Drug-induced RLS is a recognized but uncommon adverse effect.
Observation:
- This study reports on two new cases of olanzapine-induced RLS, adding to the nine previously documented.
- Patients experienced RLS symptoms at olanzapine doses ranging from 2.5 to 20mg.
- Symptoms resolved upon dose reduction or olanzapine discontinuation.
Findings:
- A dose-dependent relationship exists between olanzapine and RLS symptom severity.
- Patients with a family history of idiopathic RLS are more susceptible.
- Treatment options include dose adjustment, discontinuation, or alternative antipsychotics; medication adjustments showed variable success.
Implications:
- Clinicians should consider olanzapine as a potential cause of RLS, especially in predisposed individuals.
- Gradual dose titration of olanzapine may mitigate the risk of RLS.
- Discontinuation of olanzapine is the primary treatment for olanzapine-induced RLS.
Related Concept Videos
01:27Restless Leg Syndrome and Night Terrors
926
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
926
01:15REM Sleep Behavior Disorder
2.9K
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
2.9K
01:20Antiepileptic Drugs: Potassium Channel Activators
1.0K
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
1.0K
01:26Psychosis: Goals of Pharmacotherapy
699
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
699
01:21Antipsychotic Drugs: Typical and Atypical Agents
1.3K
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
1.3K
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
960
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
960